Hyperinsulinemia is present in T2D due to insulin resistance, and supraphysiological levels are hypothesized to amplify insulin’s mitogenic effect, both through direct receptor activation and an increase in IGF-1 signaling [40], promoting the proliferation of malignant cells. The gene discussed is IGF1; the disease is hyperinsulinism.